KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Other Non-Current Liabilities (2016 - 2025)

Globus Medical (GMED) has disclosed Other Non-Current Liabilities for 15 consecutive years, with $105.0 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Non-Current Liabilities rose 316.47% year-over-year to $105.0 million, compared with a TTM value of $105.0 million through Jun 2025, up 316.47%, and an annual FY2024 reading of $21.5 million, down 12.46% over the prior year.
  • Other Non-Current Liabilities was $105.0 million for Q2 2025 at Globus Medical, down from $118.1 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $118.1 million in Q1 2025 and bottomed at $10.3 million in Q4 2022.
  • Average Other Non-Current Liabilities over 5 years is $47.4 million, with a median of $30.6 million recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities soared 499.94% in 2021, then plummeted 61.43% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $12.6 million in 2021, then decreased by 18.17% to $10.3 million in 2022, then skyrocketed by 137.76% to $24.6 million in 2023, then fell by 12.46% to $21.5 million in 2024, then surged by 387.54% to $105.0 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for GMED at $105.0 million in Q2 2025, $118.1 million in Q1 2025, and $21.5 million in Q4 2024.